Vertex to Participate in Upcoming March Investor Conferences

Rhea-AI Summary

Vertex Pharmaceuticals (VRTX) has announced its participation in three major investor conferences in March 2025. Stuart Arbuckle, EVP and COO, and David Altshuler, EVP of Global Research and CSO, will join a fireside chat at the TD Cowen 45th Annual Health Care Conference on March 3 at 3:10 p.m. ET.

Charles Wagner, EVP and CFO, along with Dr. Altshuler, will participate in the 2025 Leerink Partners Global Healthcare Conference on March 10 at 10:00 a.m. ET. Additionally, Susie Lisa, SVP of Investor Relations, and Miroslava Minkova, Executive Director of IR, will attend the Jefferies Biotech on the Beach Summit on March 11.

Live webcasts of management presentations will be accessible through the company's website at www.vrtx.com under the Investors section, with replays available afterward.

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences.

• Stuart Arbuckle, Executive Vice President and Chief Operating Officer, and David Altshuler, M.D., Ph.D., Executive Vice President, Global Research, and Chief Scientific Officer will participate in a fireside chat at the TD Cowen 45^th Annual Health Care Conference on Monday, March 3, 2025, at 3:10 p.m. ET.
• Charles Wagner, Executive Vice President and Chief Financial Officer, and Dr. Altshuler will participate in a fireside chat at the 2025 Leerink Partners Global Healthcare Conference on Monday, March 10, 2025, at 10:00 a.m. ET.
• Susie Lisa, Senior Vice President, Investor Relations and Miroslava Minkova, Executive Director, Investor Relations will participate in the Jefferies Biotech on the Beach Summit on Tuesday, March 11, 2025.

A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com, in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1.

Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 15 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex’s history of innovation, visit www.vrtx.com or follow us on LinkedIn, Facebook, Instagram, YouTube and X.

(VRTX-WEB)

View source version on businesswire.com: https://www.businesswire.com/news/home/20250218073793/en/

Vertex Pharmaceuticals Incorporated

Investors:

InvestorInfo@vrtx.com

Source: Vertex Pharmaceuticals Incorporated

FAQ

Which investor conferences will Vertex (VRTX) attend in March 2025?

Vertex will participate in three conferences: TD Cowen 45th Annual Health Care Conference (March 3), Leerink Partners Global Healthcare Conference (March 10), and Jefferies Biotech on the Beach Summit (March 11).

What time is Vertex's (VRTX) presentation at the TD Cowen conference?

Vertex's fireside chat at the TD Cowen conference is scheduled for March 3, 2025, at 3:10 p.m. ET.

How can investors access Vertex's (VRTX) March 2025 conference presentations?

Investors can access live webcasts of the presentations through Vertex's website (www.vrtx.com) in the 'Investors' section under 'News and Events'. Replays will be archived on the website.

Which Vertex executives will present at the Leerink Partners conference in March 2025?

Charles Wagner, EVP and CFO, and David Altshuler, EVP of Global Research and CSO, will participate in a fireside chat at the Leerink Partners conference.